Read More Pharma Industry News Genentech’s giredestrant shows breakthrough survival benefit in early breast cancer: What lidERA revealed Genentech’s giredestrant delivers historic survival benefit in early-stage breast cancer. Explore how the lidERA trial may redefine endocrine therapy. byVenkateshNovember 18, 2025